Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
Argus Health
Fish and Richardson
Citi
Teva
Boehringer Ingelheim
Chinese Patent Office
Cipla

Generated: May 24, 2018

DrugPatentWatch Database Preview

Claims for Patent: 9,050,309

« Back to Dashboard

Summary for Patent: 9,050,309
Title:DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
Abstract: DPA-enriched pharmaceutical compositions of polyunsaturated fatty acids in free acid form, therapeutic methods for their use, and processes for refining the compositions from fish oil are presented.
Inventor(s): Maines; Timothy J. (Potomac, MD), Machielse; Bernardus N M (North Potomac, MD), Mehta; Bharat M. (Mendham, NJ), Wisler; Gerald L. (Windermere, FL), Davidson; Michael H. (Highland Park, IL), Wood; Peter Ralph (Cotherstone, GB)
Assignee: Omthera Pharmaceuticals, Inc. (Princeton, NJ) Chrysalis Pharma AG (Sacheln, CH)
Application Number:13/797,557
Patent Claims: 1. A pharmaceutical composition, comprising: EPA, in a weight percent amount of 50% to 60%; DHA, in a weight percent amount of 17% to 23%; DPA, in a weight percent amount of 1% to 8%; wherein at least 90% by weight of the polyunsaturated fatty acid in the composition is present in the free acid form.

2. The pharmaceutical composition of claim 1, wherein at least 95% by weight of the polyunsaturated fatty acid in the composition is present in the free acid form.

3. The pharmaceutical composition of claim 1, wherein DPA is present in a weight percent amount of at least 1.5%.

4. The pharmaceutical composition of claim 3, wherein DPA is present in a weight percent amount of at least 2%.

5. The pharmaceutical composition of claim 4, wherein DPA is present in a weight percent amount of at least 2.5%.

6. The pharmaceutical composition of claim 5, wherein DPA is present in a weight percent amount of at least 3%.

7. The pharmaceutical composition of claim 6, wherein DPA is present in a weight percent amount of at least 3.5%.

8. The pharmaceutical composition of claim 7, wherein DPA is present in a weight percent amount of at least 4%.

9. The pharmaceutical composition of claim 8, wherein DPA is present in a weight percent amount of at least 4.5%.

10. The pharmaceutical composition of claim 1, wherein the composition comprises a unit dose of at least 500 mg of the composition.

11. The pharmaceutical composition of claim 1, wherein the composition comprises a unit dose of about 1 gram of the composition.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
Express Scripts
Fuji
Cantor Fitzgerald
US Department of Justice
Teva
McKinsey
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.